AtriCure ATRC
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 94th percentile, 5-year average -23.8x
#2910 of 2993 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 87th percentile, 5-year average 4.1x
#4454 of 5330 stocks by PB (1 = cheapest)
Around its usual level · 58th percentile, 5-year average 5.1x
#3917 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 5.43 | – | 4.07 | 87% (pricier than usual) | #4454 of 5330 (1 = cheapest) |
| PE | 183.35 | 207.46 | -23.79 | 94% (pricier than usual) | #2910 of 2993 (1 = cheapest) |
| PS | 4.91 | 4.36 | 5.10 | 58% (pricier than usual) | #3917 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ATRC.
Sign in to join the discussion.